Patient Guide: Testing Experimental Anti-cancer Drug SLC-391 with an Approved Immunotherapy Drug, Pembrolizumab, for Advanced Lung Cancers

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • ✓ Get matched to the right study location for you
  • ✓ Connect directly with study coordinators at 13 participating sites
  • ✓ Understand eligibility with our simplified screening tool
  • ✓ Free service - we're here to help you access clinical research
Trial ID: NCTNCT05860296
Status: TERMINATED
Condition: Lung Cancer, Nonsmall Cell, Lung Cancer Stage IV, Lung Cancer Metastatic
Phase: PHASE1, PHASE2

Find a Study Location Near You

This study is available at 13 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • • Indianapolis, Indiana
  • • Lafayette, Indiana
  • • Detroit, Michigan
  • • And 10 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Testing Experimental Anti-cancer Drug SLC-391 with an Approved Immunotherapy Drug, Pembrolizumab, for Advanced Lung Cancers - Join Clinical Trial NCTNCT05860296

How to Join This Clinical Trial - NCTNCT05860296

Learn how to participate in this PHASE1, PHASE2 trial studying an investigational therapy for Lung Cancer, Nonsmall Cell, Lung Cancer Stage IV, Lung Cancer Metastatic. Current status: TERMINATED.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Lung Cancer, Nonsmall Cell, Lung Cancer Stage IV, Lung Cancer Metastatic. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Lung Cancer, Nonsmall Cell, Lung Cancer Stage IV, Lung Cancer Metastatic
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1, PHASE2 - Safety and effectiveness study
Enrollment Status
TERMINATED
Study Identifier
NCTNCT05860296 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 13 locations. Find a study site near you:

Clinical Research Site

Indianapolis, Indiana 46250 - United States

Status: RECRUITING

Clinical Research Site

Lafayette, Indiana 47905 - United States

Status: TERMINATED

Clinical Research Site

Detroit, Michigan 48201 - United States

Status: RECRUITING

Clinical Research Site

Omaha, Nebraska 68130 - United States

Status: RECRUITING

Clinical Research Site

Cleveland, Ohio 44195 - United States

Status: RECRUITING

Clinical Research Site

Oklahoma City, Oklahoma 73104 - United States

Status: RECRUITING

Clinical Research Site

Nashville, Tennessee 37203 - United States

Status: WITHDRAWN

Clinical Research Site

Edmonton, Alberta - Canada

Status: RECRUITING

Clinical Research Site

Hamilton, Ontario - Canada

Status: RECRUITING

Clinical Research Site

London, Ontario - Canada

Status: RECRUITING

And 3 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1, PHASE2 clinical trial for Lung Cancer, Nonsmall Cell, Lung Cancer Stage IV, Lung Cancer Metastatic:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai as Your Clinical Trial Matching Service

Quri.ai is a free clinical trial matching service that helps patients connect with research sites. We make it easier to:

  • Find clinical trials that match your condition
  • Get matched to the right study location near you
  • Connect directly with study coordinators
  • Understand if you qualify with simplified eligibility screening
  • Navigate the enrollment process with personalized support
  • Access new treatments through clinical research participation